Holen Sie sich die Stockscreener-App
91.42
3.78%
-3.6134
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$95.03
Offen:
$92.75
24-Stunden-Volumen:
2.15M
Relative Volume:
1.25
Marktkapitalisierung:
$14.05B
Einnahmen:
$4.28B
Nettoeinkommen (Verlust:
$1.26B
KGV:
11.57
EPS:
7.9
Netto-Cashflow:
$943.00M
1W Leistung:
-5.42%
1M Leistung:
-3.87%
6M Leistung:
+21.82%
1J Leistung:
-38.66%
1-Tages-Spanne:
$88.00
$93.80
1-Wochen-Bereich:
$88.00
$98.70
52-Wochen-Spanne:
$68.70
$156.66
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Vergleichen Sie ILMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
91.41 | 14.61B | 4.28B | 1.26B | 943.00M | 7.90 |
|
TMO
Thermo Fisher Scientific Inc
|
525.22 | 198.09B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
205.96 | 146.89B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
635.85 | 50.67B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.10 | 39.19B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.83 | 34.64B | 15.70B | 1.24B | 2.01B | 6.9036 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Bestätigt | Citigroup | Neutral |
| 2025-02-28 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-02-10 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-08-28 | Hochstufung | Argus | Hold → Buy |
| 2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Is Illumina Inc. stock safe for conservative investorsWeekly Risk Summary & Reliable Intraday Trade Alerts - newser.com
Sentiment analysis tools applied to Illumina Inc.Market Volume Summary & Low Risk Profit Maximizing Plans - newser.com
What consensus target says about Illumina Inc. (ILU) stockLong Setup & Accurate Technical Buy Alerts - newser.com
Will Illumina Inc. stock remain a Wall Street favoriteJuly 2025 Retail & Daily Oversold Bounce Ideas - newser.com
Microfluidic Market to See Booming Growth 2025-2032 | Agilent Technologies, Inc., Illumina, Inc. - openPR.com
What data driven models say about Illumina Inc.’s futureMarket Trend Review & Real-Time Market Sentiment Reports - newser.com
Aberdeen Group plc Trims Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. (ILMN) Stock Analysis: Exploring a Potential 18.82% Upside in Genomic Innovation - DirectorsTalk Interviews
Single-cell Analysis Market to Reach USD 12.29 Billion by 2032, Driven by Expanding Oncology Research and Advanced Genomics – SNS Insider - GlobeNewswire Inc.
United States Biological Multiplex Assays Market Insights: - openPR.com
Why Illumina Inc. stock could see breakout soonQuarterly Growth Report & Community Driven Trade Alerts - newser.com
3,362 Shares in Illumina, Inc. $ILMN Purchased by waypoint wealth counsel - MarketBeat
A Look at Illumina’s (ILMN) Valuation Following the Launch of BioInsight and Executive Team Updates - Yahoo Finance
Illumina, Inc. $ILMN Shares Purchased by KLP Kapitalforvaltning AS - MarketBeat
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know - Yahoo Finance
MarketsFinancial Advisors - FinancialContent
Can volume confirm reversal in Illumina Inc.2025 Short Interest & Comprehensive Market Scan Insights - newser.com
3,608 Shares in Illumina, Inc. $ILMN Bought by Allegiance Financial Group Advisory Services LLC - MarketBeat
Illumina Inc. stock momentum explainedOptions Play & Real-Time Volume Spike Alerts - newser.com
QRG Capital Management Inc. Has $711,000 Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Precision proteomics with Illumina Protein Prep - Illumina
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Illumina Inc. stock trendline breakdown2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
Illumina Inc. stock volume spike explainedWeekly Market Report & Reliable Price Breakout Alerts - newser.com
Illumina (NASDAQ:ILMN) Earns Sell (D+) Rating from Weiss Ratings - MarketBeat
Illumina, Inc. (ILMN): A Bull Case Theory - MSN
Is Illumina Inc. (ILU) stock positioned for secular growthIPO Watch & Community Verified Trade Signals - newser.com
Wealthcare Advisory Partners LLC Has $851,000 Position in Illumina, Inc. $ILMN - MarketBeat
Illumina’s SWOT analysis: genetic sequencing giant faces headwinds By Investing.com - Investing.com Australia
Celebrating milestones and the future of oncology in China - Illumina
Mirae Asset Global Investments Co. Ltd. Reduces Stake in Illumina, Inc. $ILMN - MarketBeat
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - sharewise.com
Illumina, Inc. Experiences Evaluation Revision Amidst Ongoing Market Challenges - Markets Mojo
Illumina (ILMN) Analyst Rating Update: Evercore ISI Lowers Price Target | ILMN Stock News - GuruFocus
Illumina (NASDAQ:ILMN) Price Target Lowered to $132.00 at Evercore ISI - MarketBeat
Ultima Genomics UG 100 platform vs. Illumina NovaSeq X Series whole-genome sequencing benchmarking - Illumina
Assessing Illumina’s Value After 6% Weekly Rally and New Cost-Cutting Initiative - Yahoo
Slow Capital Inc. Sells 23,118 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo
Illumina Stock Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
How to interpret RSI for Illumina Inc. stock2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Will Illumina’s (ILMN) AI-Powered BioInsight Reshape Its Precision Medicine Strategy? - Yahoo Finance
United States RNA Sequencing Market Set to Revolutionize - openPR.com
Will Illumina Inc. (ILU) stock test record highs in 2025Buy Signal & Verified Swing Trading Watchlists - newser.com
Will Illumina Inc. stock benefit from commodity pricesTrade Signal Summary & Low Risk Entry Point Guides - newser.com
Is Illumina Inc. still worth holding after the dipQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
Backtesting results for Illumina Inc. trading strategiesJuly 2025 Recap & High Accuracy Buy Signal Tips - newser.com
Will Illumina Inc. stock continue dividend increasesJuly 2025 Closing Moves & Momentum Based Trading Signals - newser.com
A Look at Illumina’s (ILMN) Valuation Following Analyst Skepticism on BioInsight and New Partnerships - Sahm
Legacy Trust Trims Stake in Illumina, Inc. $ILMN - MarketBeat
Can Illumina Inc. stock resist sector downturnsTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
1.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):